We suggest that the contrasting effects of GBA deletion, particularly those in hepatocellular carcinoma, are likely due to differences in the molecular alterations of sphingolipids that take place during transformation in these histologically different tumor-derived cell lines. Here, GBA1 is linked to hepatocellular carcinoma.